Otsuka Holdings
4578.T
#725
Rank
NZ$58.66 B
Marketcap
NZ$111.07
Share price
-0.34%
Change (1 day)
31.01%
Change (1 year)
Otsuka Pharmaceutical Co., Ltd. is a Japanese pharmaceutical company involved in the R&D of drugs and healing methods for respiratory diseases, eye diseases, cardiovascular diseases, neurological and mental diseases as well as Parkinson's, tuberculosis and cancer.

Earnings for Otsuka Holdings (4578.T)

Earnings in 2023: NZ$1.76 Billion

According to Otsuka Holdings 's latest financial reports the company's current earnings are NZ$14.47 Billion. In 2023 the company made an earning of NZ$1.76 Billion a decrease over its 2022 earnings that were of NZ$2.22 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Otsuka Holdings from 2010 to 2023

Annual earnings

Year Earnings Change
2023NZ$1.76 B-20.93%
2022NZ$2.22 B-12.7%
2021NZ$2.55 B-19.92%
2020NZ$3.18 B13.9%
2019NZ$2.79 B52.07%
2018NZ$1.83 B11.22%
2017NZ$1.65 B-36.03%
2016NZ$2.58 B31.15%
2015NZ$1.97 B
2013NZ$4.09 B33.52%
2012NZ$3.06 B-4.65%
2011NZ$3.21 B45.53%
2010NZ$2.20 B